The primary (and inactive) enteric metabolite of 5aminosalicylate is N-acetyl-5-aminosalicylate. Previous studies have demonstrated acetylation of this anti-inflammatory agent by intestinal and bacterial homogenates. To assess the contribution of anerobic bacteria to the N-acetylation in vivo, we ha
Enteric bacteria may play a role in mammalian arsenic metabolism
β Scribed by Koichi Kuroda; Kaoru Yoshida; Akira Yasukawa; Hideki Wanibuchi; Shoji Fukushima; Ginji Endo
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 80 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0268-2605
- DOI
- 10.1002/aoc.193
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The cecal content of rats administered dimethylarsinic acid for 6 months via drinking water was cultured in GAM medium with 10β mg l^β1^ of dimethylarsinic acid. Arsenic compounds in the culture were analyzed by ion chromatography with inductively coupled plasma mass spectrometry (ICβICPβMS). Dimethylarsinic acid was metabolized. Two bacterial Escherichia coli strains, A3β4 and A3β6, were isolated from the culture. These strains metabolized dimethylarsinic acid and yielded two unidentified arsenic compounds, Mβ2 and Mβ3. A3β6 methylated dimethylarsinic acid to trimethylarsine oxide. Both strains metabolized trimethylarsine oxide and yielded an unidentified arsenic compound, Mβ1. These unknown arsenic compounds were the same compounds as detected in the urine and the feces of rats administered dimethylarsinic acid. The strains reduced arsenate to arsenite efficiently. Cysteine was required for metabolism of dimethylarsinic acid by these bacteria, but glutathione was not required. These results strongly suggested that the intestinal bacteria have a different arsenic metabolism from that in mammals and that they may play a possible role in mammalian arsenic metabolism. Copyright Β© 2001 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES